PODESTA GROUP, INC. for GENZYME
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
H. Con. Res 112, Establishing the budget for the US Government for FY 2013. H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H.J. Res. 117, Continuing Appropriations Resolution, 2013.
Foreign entity interest: As the ultimate parent of Genzyme Corporation, Sanofi-aventis has an interest in the issues lobbied.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
Pharmacy PHA
Prescription Drug User Fee Act reauthorization. Product exclusivity issues. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Foreign entity interest: As the ultimate parent of Genzyme Corporation, Sanofi-aventis has an interest in the issues lobbied.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CRISTINA ANTELO | — |
| SHARON COHEN | — |
Medicare/Medicaid MMM
H. Con. Res 112, Establishing the budget for the US Government for FY 2013. Medicare issues related to end stage renal disease. Medicare reimbursement issues. ASP changes; 340B issues.
Foreign entity interest: As the ultimate parent of Genzyme Corporation, Sanofi-aventis has an interest in the issues lobbied.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
| ANTHONY PODESTA | — |
Health Issues HCR
340B issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Foreign entity interest: As the ultimate parent of Genzyme Corporation, Sanofi-aventis has an interest in the issues lobbied.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.